Skip to main content

Enzo Biochem Inc

ENZBDelisted Apr 7, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000316253

Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.

13F holders, Q2 2025

Institutional positions in Enzo Biochem Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ENZB is no longer listed, and 13F filings after Q1 2025 list far fewer holders. See Q1 2025

Institutional holders
7
−34 vs. Q1 2025
Shares held
2.95M
−10.5M (−78.0%) vs. Q1 2025
Total value
$2.00M
−$2.96M (−59.7%) vs. Q1 2025
New holders
2
2 more added
Sold out
36
1 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 7 institutions
Q1 2021: 82 institutionsQ2 2021: 72 institutionsQ3 2021: 65 institutionsQ4 2021: 59 institutionsQ1 2022: 51 institutionsQ2 2022: 54 institutionsQ3 2022: 49 institutionsQ4 2022: 52 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 39 institutionsQ4 2023: 46 institutionsQ1 2024: 41 institutionsQ2 2024: 39 institutionsQ3 2024: 43 institutionsQ4 2024: 44 institutionsQ1 2025: 41 institutionsQ2 2025: 7 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2025: $2.00M
Q1 2021: $94.6MQ2 2021: $76.6MQ3 2021: $82.9MQ4 2021: $69.0MQ1 2022: $62.0MQ2 2022: $43.8MQ3 2022: $45.6MQ4 2022: $26.8MQ1 2023: $48.1MQ2 2023: $34.7MQ3 2023: $23.1MQ4 2023: $22.7MQ1 2024: $17.6MQ2 2024: $13.5MQ3 2024: $14.2MQ4 2024: $9.71MQ1 2025: $4.96MQ2 2025: $2.00MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ENZB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20257$2.00M
Q1 202541$4.96M
Q4 202444$9.71M
Q3 202443$14.2M
Q2 202439$13.5M
Q1 202441$17.6M
Q4 202346$22.7M
Q3 202339$23.1M
Q2 202347$34.7M
Q1 202352$48.1M
Q4 202252$26.8M
Q3 202249$45.6M
Q2 202254$43.8M
Q1 202251$62.0M
Q4 202159$69.0M
Q3 202165$82.9M
Q2 202172$76.6M
Q1 202182$94.6M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q1 2025.

Institutions holding ENZB in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Oddo BHF Asset Management SAS2,575,000$1.75M0.07%+2,575,000New
RBF Capital, LLC150,000$101.7K0.01%−100,359−40.1%Reduced
Squarepoint Ops LLC140,637$95.4K0.00%+13,197+10.4%Added
XTX Topco Ltd44,880$30.4K0.00%+23,687+111.8%Added
Kempner Capital Management Inc.25,475$17.0K0.01%00.0%Unchanged
Ground Swell Capital, LLC13,761$9.33K0.02%+13,761New
Simplex Trading, LLC2$00.00%00.0%Unchanged
Harbert Fund Advisors, Inc.0$00.00%−5,175,913−100.0%Sold out
Renaissance Technologies LLC0$00.00%−2,082,229−100.0%Sold out
Vanguard Group Inc0$00.00%−1,859,002−100.0%Sold out
BlackRock, Inc.0$00.00%−957,775−100.0%Sold out
Mink Brook Asset Management LLC0$00.00%−807,899−100.0%Sold out
Geode Capital Management, LLC0$00.00%−431,042−100.0%Sold out
Wittenberg Investment Management, Inc.0$00.00%−274,095−100.0%Sold out
Citadel Advisors LLC0$00.00%−210,877−100.0%Sold out
State Street Corp0$00.00%−168,881−100.0%Sold out
Lepercq De Neuflize Asset Management LLC0$00.00%−156,303−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−138,126−100.0%Sold out
BBR Partners, LLC0$00.00%−100,000−100.0%Sold out
Nierenberg Investment Management Company, Inc.0$00.00%−88,555−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−77,200−100.0%Sold out
Morgan Stanley0$00.00%−67,342−100.0%Sold out
Northern Trust Corp0$00.00%−67,204−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−60,041−100.0%Sold out
Lazard Asset Management LLC0$00.00%−50,453−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−44,800−100.0%Sold out
UBS Group AG0$00.00%−45,713−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−19,746−100.0%Sold out
Paradigm Financial Partners, LLC0$00.00%−19,500−100.0%Sold out
Baader Bank INC0$00.00%−22,678−100.0%Sold out
Raymond James Financial Inc0$00.00%−17,016−100.0%Sold out
Shulman DeMeo Asset Management LLC0$00.00%−15,487−100.0%Sold out
Virtu Financial LLC0$00.00%−11,920−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−10,026−100.0%Sold out
Bank of America Corp0$00.00%−3,962−100.0%Sold out
Medallion Wealth Advisors, LLC0$00.00%−2,800−100.0%Sold out
JPMorgan Chase & Co0$00.00%−1,915−100.0%Sold out
Fort Vancouver Investment Management, LLC0$00.00%−1,599−100.0%Sold out
Wells Fargo & Company0$00.00%−793−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−700−100.0%Sold out
FMR LLC0$00.00%−429−100.0%Sold out
Sound Income Strategies, LLC0$00.00%−10−100.0%Sold out
Royal Bank of Canada0$00.00%−1,000−100.0%Sold out